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The stenting versus aggressive medical therapy 
for intracranial artery stenosis (SAMMPRIS) 
trial compared aggressive medical therapy to 
aggressive medical therapy and percutaneous 
angioplasty and stenting (PTAS) in patients 
with symptomatic intracranial atheroscle-
rotic disease (ICAD; Chimowitz et al., 2011). 
The trial was halted when a higher 30-day rate 
of stroke and death was present in the PTAS 
compared to the aggressive medical therapy 
group (14.7 vs. 5.8%, p = 0.002).
SAMMPRIS highlights the evolving defi-
nition and improving efficacy of aggressive 
medical therapy including aspirin and clopi-
dogrel, statin, and antihypertensive treat-
ments. SAMMPRIS sets the new standard 
for periprocedural stroke and death rates 
which neurointerventionalists and devices 
must achieve to demonstrate superiority 
of PTAS to aggressive medical therapy. The 
data from SAMMPRIS may allow a better 
understanding of underlying mechanism for 
adverse events such as intracranial hemor-
rhages related to PTAS and result in new 
strategies for preventing such events.
The results should not undermine the 
high risk of recurrent stroke in patients with 
symptomatic ICAD despite aggressive med-
ical treatment. Several subgroups of ICAD 
patients at high risk of ischemic events have 
been identified such as those with high grade 
stenosis, posterior circulation involvement, 
precipitation of ischemic symptoms by sys-
temic blood pressure changes, and recurrent 
ischemic events (Thijs and Albers, 2000). 
Until the next stent emerges, intracranial 
angioplasty (Marks et al., 2005; Nguyen 
et al., 2011) may be an alternative for this 
subgroup and should be evaluated against 
aggressive medical therapy in a randomized 
trial.
RefeRences
Chimowitz, M. I., Lynn, M. J., Derdeyn, C. P., Turan, T. 
N., Fiorella, D., Lane, B. F., Janis, S., Lutsep, H. L., 
Barnwell, S. L., Waters, M. F., Hoh, B. L., Hourihane, 
J. M., Levy, E. I., Alexandrov, A. V., Harrigan, M. R., 
Chiu, D., Klucznik, R. P., Clark, J. M., McDougall, C. 
G., Johnson, M. D., Pride, L., Torbey, M. T., Zaidat, 
O. O., Rumboldt, Z., Cloft, H. J., and SAMMPRIS 
Trial Investigators. (2011). Stenting versus aggressive 
medical therapy for intracranial artery stenosis. N. 
Engl. J. Med. 365, 993–1003.
Marks, M. P., Marcellus, M. L., Do, H. M., Schraedley-
Desmond, P. K., Steinberg, G. K., Tong, D. C., and 
Albers, G. W. (2005). Intracranial angioplasty with-
out stenting for symptomatic atherosclerotic stenosis: 
long-term follow-up. Am. J. Neuroradiol. 26, 525–530.
Nguyen, T., Zaidat, O. O., Gupta, R., Nogueira, R. G., 
Tariq, N., Kalia, J. S., Norbash, A. M., and Qureshi, A. 
I. (2011). Balloon angioplasty for intracranial athero-
sclerotic disease. Stroke 42, 107–111.
Thijs, V. N., and Albers, G. W. (2000). Symptomatic 
intracranial atherosclerosis: outcome of patients who 
fail antithrombotic therapy. Neurology 55, 490–498.
Received: 01 November 2011; accepted: 17 November 2011; 
published online: 20 December 2011.
Citation: Nguyen TN, Lazzaro MA and Qureshi AI (2011) 
New standards for intracranial atherosclerotic disease treat-
ment. Front. Neur. 2:77. doi: 10.3389/fneur.2011.00077
This article was submitted to Frontiers in Endovascular 
and Interventional Neurology, a specialty of Frontiers in 
Neurology.
Copyright © 2011 Nguyen, Lazzaro and Qureshi. This is 
an open-access article distributed under the terms of the 
Creative Commons Attribution Non Commercial License, 
which permits non-commercial use, distribution, and repro-
duction in other forums, provided the original authors and 
source are credited.
www.frontiersin.org  December 2011  | Volume 2  |  Article 77  |  1
General Commentary 
published: 20 December 2011
doi: 10.3389/fneur.2011.00077